NAMPT and Miyoshi myopathy: Pharmacological inhibition of nicotinamide phosphoribosyl transferase (NAMPT), a key enzyme in the NAD+ synthesis pathway, with FK866 sensitized MM cells to RV oncolysis, causing mitochondrial dysfunction and promoting autophagy and cell death (51).